Literature DB >> 33505248

TRPV1 Supports Axogenic Enhanced Excitability in Response to Neurodegenerative Stress.

Michael L Risner1, Nolan R McGrady1, Andrew M Boal1, Silvia Pasini1, David J Calkins1.   

Abstract

Early progression in neurodegenerative disease involves challenges to homeostatic processes, including those controlling axonal excitability and dendritic organization. In glaucoma, the leading cause of irreversible blindness, stress from intraocular pressure (IOP) causes degeneration of retinal ganglion cells (RGC) and their axons which comprise the optic nerve. Previously, we discovered that early progression induces axogenic, voltage-gated enhanced excitability of RGCs, even as dendritic complexity in the retina reduces. Here, we investigate a possible contribution of the transient receptor potential vanilloid type 1 (TRPV1) channel to enhanced excitability, given its role in modulating excitation in other neural systems. We find that genetic deletion of Trpv1 (Trpv1 -/-) influences excitability differently for RGCs firing continuously to light onset (αON-Sustained) vs. light offset (αOFF-Sustained). Deletion drives excitability in opposing directions so that Trpv1 -/- RGC responses with elevated IOP equalize to that of wild-type (WT) RGCs without elevated IOP. Depolarizing current injections in the absence of light-driven presynaptic excitation to directly modulate voltage-gated channels mirrored these changes, while inhibiting voltage-gated sodium channels and isolating retinal excitatory postsynaptic currents abolished both the differences in light-driven activity between WT and Trpv1 -/- RGCs and changes in response due to IOP elevation. Together, these results support a voltage-dependent, axogenic influence of Trpv1 -/- with elevated IOP. Finally, Trpv1 -/- slowed the loss of dendritic complexity with elevated IOP, opposite its effect on axon degeneration, supporting the idea that axonal and dendritic degeneration follows distinctive programs even at the level of membrane excitability.
Copyright © 2021 Risner, McGrady, Boal, Pasini and Calkins.

Entities:  

Keywords:  TRPV1; axon; dendritic pruning; glaucoma; neurodegeneration; retinal ganglion cells

Year:  2021        PMID: 33505248      PMCID: PMC7829306          DOI: 10.3389/fncel.2020.603419

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  65 in total

1.  Functional specialization of the axon initial segment by isoform-specific sodium channel targeting.

Authors:  Tatiana Boiko; Audra Van Wart; John H Caldwell; S Rock Levinson; James S Trimmer; Gary Matthews
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

2.  Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.

Authors:  Gorazd B Stokin; Concepción Lillo; Tomás L Falzone; Richard G Brusch; Edward Rockenstein; Stephanie L Mount; Rema Raman; Peter Davies; Eliezer Masliah; David S Williams; Lawrence S B Goldstein
Journal:  Science       Date:  2005-02-25       Impact factor: 47.728

3.  Input resistance, electrical excitability, and size of ventral horn cells in cat spinal cord.

Authors:  D Kernell
Journal:  Science       Date:  1966-06-17       Impact factor: 47.728

4.  Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress.

Authors:  Rebecca M Sappington; Tatiana Sidorova; Nicholas J Ward; Rohini Chakravarthy; Karen W Ho; David J Calkins
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

5.  Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.

Authors:  Nicholas J Ward; Karen W Ho; Wendi S Lambert; Carl Weitlauf; David J Calkins
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

6.  Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis.

Authors:  Brigitte van Zundert; Marieke H Peuscher; Meri Hynynen; Adam Chen; Rachael L Neve; Robert H Brown; Martha Constantine-Paton; Mark C Bellingham
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

7.  Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.

Authors:  Abdellatif Benraiss; Su Wang; Stephanie Herrlinger; Xiaojie Li; Devin Chandler-Militello; Joseph Mauceri; Hayley B Burm; Michael Toner; Mikhail Osipovitch; Qiwu Jim Xu; Fengfei Ding; Fushun Wang; Ning Kang; Jian Kang; Paul C Curtin; Daniela Brunner; Martha S Windrem; Ignacio Munoz-Sanjuan; Maiken Nedergaard; Steven A Goldman
Journal:  Nat Commun       Date:  2016-06-07       Impact factor: 14.919

8.  Four alpha ganglion cell types in mouse retina: Function, structure, and molecular signatures.

Authors:  Brenna Krieger; Mu Qiao; David L Rousso; Joshua R Sanes; Markus Meister
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

Review 9.  Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma.

Authors:  Denise M Inman; Mohammad Harun-Or-Rashid
Journal:  Front Neurosci       Date:  2017-03-30       Impact factor: 4.677

10.  Tailoring of the axon initial segment shapes the conversion of synaptic inputs into spiking output in OFF-α T retinal ganglion cells.

Authors:  Paul Werginz; Vineeth Raghuram; Shelley I Fried
Journal:  Sci Adv       Date:  2020-09-11       Impact factor: 14.136

View more
  7 in total

1.  Axon hyperexcitability in the contralateral projection following unilateral optic nerve crush in mice.

Authors:  Nolan R McGrady; Joseph M Holden; Marcio Ribeiro; Andrew M Boal; Michael L Risner; David J Calkins
Journal:  Brain Commun       Date:  2022-10-03

2.  Intrinsic Morphologic and Physiologic Development of Human Derived Retinal Ganglion Cells In Vitro.

Authors:  Michael L Risner; Silvia Pasini; Xitiz Chamling; Nolan R McGrady; Jeffrey L Goldberg; Donald J Zack; David J Calkins
Journal:  Transl Vis Sci Technol       Date:  2021-08-12       Impact factor: 3.048

Review 3.  Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration.

Authors:  Andrew M Boal; Michael L Risner; Melissa L Cooper; Lauren K Wareham; David J Calkins
Journal:  Cells       Date:  2021-06-02       Impact factor: 6.600

4.  Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma.

Authors:  Michael L Risner; Silvia Pasini; Nolan R McGrady; David J Calkins
Journal:  Mol Neurobiol       Date:  2022-01-05       Impact factor: 5.590

5.  Sensitivity to extracellular potassium underlies type-intrinsic differences in retinal ganglion cell excitability.

Authors:  Andrew M Boal; Nolan R McGrady; Michael L Risner; David J Calkins
Journal:  Front Cell Neurosci       Date:  2022-08-05       Impact factor: 6.147

6.  Involvement of transient receptor potential channels in ocular diseases: a narrative review.

Authors:  Tian-Jing Yang; Yang Yu; Jing-Yi Yang; Jin-Jing Li; Jun-Ya Zhu; João Alexandre Cardoso Vieira; Qin Jiang
Journal:  Ann Transl Med       Date:  2022-08

7.  Neuroprotection by WldS depends on retinal ganglion cell type and age in glaucoma.

Authors:  Michael L Risner; Silvia Pasini; Nolan R McGrady; Karis B D'Alessandro; Vincent Yao; Melissa L Cooper; David J Calkins
Journal:  Mol Neurodegener       Date:  2021-06-05       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.